| No D3 Severe AKI | D3 Severe AKI | p-value |
---|---|---|---|
N (%cohort) | 284 (78) | 79 (22) | – |
Age, years | 9.6 (3.8–16.3) | 10.3 (2.1–16.5) | 0.54 |
Male sex, n (%) | 144 (51) | 43 (54) | 0.56 |
History of Transplant | 16 (6) | 18 (23) |  < 0.001 |
Severity of Illness | |||
PRISM III | 8 (4–12) | 13 (8–17) |  < 0.001 |
PERSEVERE-II Mortality Probability | 0.007 (0.007–0.167) | 0.189 (0.007–0.333) |  < 0.001 |
Baseline SCr, mg/dl | 0.37 (0.26–0.5) | 0.30 (0.2–0.46) | 0.010 |
Baseline known, n (%) | 149 (52) | 56 (71) | 0.003 |
D1 Vasoactive Medications, n (%) | 198 (70) | 70 (89) |  < 0.001 |
D1 VIS | 5.0 (0–14) | 17.0 (5.5–36.5) |  < 0.001 |
D1 Mechanical Ventilation, n (%) | 142 (50) | 60 (76) |  < 0.001 |
D1 Fluid Balance (%FB) | 3.5 (1.1–6.5) | 4.9 (2.2–9.1) | 0.005 |
D1 SCr > Baseline | 1.2 (0.9–1.6) | 2.8 (1.7–4.4) |  < 0.001 |
D1 Platelet Count (× 103/uL) | 172 (88–273) | 91 (39–227) |  < 0.001 |
PICU Free Days | 24 (16–26) | 4 (0–20) |  < 0.001 |
28-day Mortality, n (%) | 11 (4) | 15 (19) RR 4.9 (2.4–10.2) |  < 0.001  < 0.001 |